Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Nothing has changed , 70% make it to Phase 2 , wait

<< Previous

Bullboard Posts

Next >>

Comment by 1mattmanon Mar 17, 2022 12:08pm

137 Views

Post# 34522207

RE:RE:Nothing has changed , 70% make it to Phase 2 , wait

Exciting isn't it. Like a roller coaster, up and down. I'm pissed about my stock but not going to bash it like you. It'll come and I'm waiting. If another few months, oh well. Which company do you work for? Only people who provide your type of info have personal/business reasons to do so. Good luck, I'm sure you do well.

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?